Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COM
-
Number of holders
-
24
-
Total 13F shares, excl. options
-
4,519,327
-
Shares change
-
-114,397
-
Total reported value, excl. options
-
$21,962,000
-
Value change
-
-$879,212
-
Number of buys
-
12
-
Number of sells
-
-6
-
Price
-
$4.83
Significant Holders of ARGOS THERAPEUTICS INC - COM (ARGS) as of Q3 2015
25 filings reported holding ARGS - ARGOS THERAPEUTICS INC - COM as of Q3 2015.
ARGOS THERAPEUTICS INC - COM (ARGS) has 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4,519,327 shares
.
Largest 10 shareholders include WASATCH ADVISORS INC (2,298,711 shares), AWM Investment Company, Inc. (719,305 shares), CAISSE DE DEPOT ET PLACEMENT DU QUEBEC (317,900 shares), WALL STREET ASSOCIATES (257,900 shares), ALTRINSIC GLOBAL ADVISORS LLC (212,505 shares), VANGUARD GROUP INC (157,165 shares), Alyeska Investment Group, L.P. (144,025 shares), Pinnacle Summer Investments, Inc. (90,733 shares), PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO (77,906 shares), and GEODE CAPITAL MANAGEMENT, LLC (45,170 shares).
This table shows the top 24 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.